Terry Boodhoo

822 total citations
9 papers, 528 citations indexed

About

Terry Boodhoo is a scholar working on Neurology, Dermatology and Physiology. According to data from OpenAlex, Terry Boodhoo has authored 9 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 3 papers in Dermatology and 3 papers in Physiology. Recurrent topics in Terry Boodhoo's work include Botulinum Toxin and Related Neurological Disorders (6 papers), Neurological disorders and treatments (3 papers) and Sympathectomy and Hyperhidrosis Treatments (2 papers). Terry Boodhoo is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (6 papers), Neurological disorders and treatments (3 papers) and Sympathectomy and Hyperhidrosis Treatments (2 papers). Terry Boodhoo collaborates with scholars based in United States, Canada and Germany. Terry Boodhoo's co-authors include Ewa Niżankowska, Sven‐Erik Dahlén, A Szczeklik, Grazyna Pinis, Grażyna Bochenek, Maria Kumlin, O. Zetterström, Louise M. Dubé, Linda J. Swanson and Barbro Dahlén and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of the American Academy of Dermatology and Movement Disorders.

In The Last Decade

Terry Boodhoo

9 papers receiving 497 citations

Peers

Terry Boodhoo

PHYSI

NEURO

PRM

PHARM

R. Jankowski France

Kyung Eun Lee South Korea

Maïté Manise Belgium

Nesrine A Mohamed Egypt

I Wahedna United Kingdom

Jia‐Heng Shie Taiwan

Ji Woong Park South Korea

Jiann‐Chyun Lin Taiwan

Selma El Hassani Morocco

Y Yamashita Japan

R. Jankowski France

Terry Boodhoo

165 ×0.5

PHYSI

11 ×0.1

NEURO

70 ×0.5

PRM

8 ×0.1

PHARM

182 ×2.0

Citations per year, relative to Terry Boodhoo Terry Boodhoo (= 1×) peers R. Jankowski

Countries citing papers authored by Terry Boodhoo

Since Specialization

Citations

This map shows the geographic impact of Terry Boodhoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Boodhoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Boodhoo more than expected).

Fields of papers citing papers by Terry Boodhoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry Boodhoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Boodhoo. The network helps show where Terry Boodhoo may publish in the future.

Co-authorship network of co-authors of Terry Boodhoo

This figure shows the co-authorship network connecting the top 25 collaborators of Terry Boodhoo. A scholar is included among the top collaborators of Terry Boodhoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry Boodhoo. Terry Boodhoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Jankovic, Joseph, Jean Carruthers, Markus Naumann, et al.. (2023). Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis. Toxins. 15(5). 342–342. 16 indexed citations

Brin, Mitchell F., Koen De Boulle, Steven Liew, et al.. (2023). Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysis. JAAD International. 14. 4–18. 3 indexed citations

DuBois, Janet, Suzanne Bruce, Daniel Stewart, et al.. (2021). Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial. Clinical Cosmetic and Investigational Dermatology. Volume 14. 1507–1517. 6 indexed citations

Jankovic, Joseph, Jean Carruthers, Markus Naumann, et al.. (2021). Neutralizing antibody conversion with onabotulinumtoxinA from global studies across multiple indications in nearly 30,000 patient records: A meta-analysis. Toxicon. 190. S35–S35. 4 indexed citations

Brashear, Allison, Marta Banach, Blair Schoene, et al.. (2020). Safety and Stability of Pulmonary Function in Patients with Decreased Respiratory Function Treated for Spasticity with OnabotulinumtoxinA. Toxins. 12(10). 661–661. 2 indexed citations

Naumann, Markus, Alastair Carruthers, Jean Carruthers, et al.. (2010). Meta‐analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications. Movement Disorders. 25(13). 2211–2218. 109 indexed citations

Brin, Mitchell F., Terry Boodhoo, Janice M. Pogoda, et al.. (2009). Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: A meta-analysis of individual patient data from global clinical registration studies in 1678 participants. Journal of the American Academy of Dermatology. 61(6). 961–970.e11. 94 indexed citations

Steinberg, Steven M., Rocco C. Venuto, David O. Taylor, et al.. (2003). Randomized, open-label preference study of two cyclosporine capsule formulations (usp modified) in stable solid-organ transplant recipients. Clinical Therapeutics. 25(7). 2037–2052. 3 indexed citations

Dahlén, Barbro, Ewa Niżankowska, A Szczeklik, et al.. (1998). Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics. American Journal of Respiratory and Critical Care Medicine. 157(4). 1187–1194. 291 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact